3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
53
Breast Neoplasms
26
Lung Neoplasms
21
Triple Negative Breast Neoplasms
16
Neoplasm Metastasis
16
Pancreatic Neoplasms
15
Neoplasms
15
Stomach Neoplasms
14
Colorectal Neoplasms
14
Head and Neck Neoplasms
12
Esophageal Neoplasms
12
Esophageal Squamous Cell Carcinoma
11
Uterine Cervical Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
10
Small Cell Lung Carcinoma
10
Rectal Neoplasms
9
Ovarian Neoplasms
8
Leukemia, Myeloid, Acute
8
Recurrence
7
Nasopharyngeal Carcinoma
7
Glioblastoma
5
Fallopian Tube Neoplasms
5
Cholangiocarcinoma
5
Urinary Bladder Neoplasms
4
Sarcoma
4
Oropharyngeal Neoplasms
4
Mouth Neoplasms
4
Lymphoma
4
Endometrial Neoplasms
4
Colonic Neoplasms
4
Interventions
pembrolizumab
5
Nivolumab
3
durvalumab
2
tremelimumab
1
relatlimab
1
fludarabine phosphate
1
fludarabine
1
avelumab
1
atezolizumab
1
Therapeutics
1
Temozolomide
1
Surgical Procedures, Operative
1
Neoadjuvant Therapy
1
Ipilimumab
1
Injections
1
Docetaxel
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Bevacizumab
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Microsatellite Instability
×
Drug Therapy
×
1 year
×
Clear all
No trials found.